WATCH: The new EU Clinical Trials Regulation – IP Considerations

As part of a lifecycle IP strategy for a therapeutic product, it can be important to protect inventions arising during the clinical development of the product.  Disclosures made during the clinical trial process can have a significant impact on whether it is possible to protect these inventions, so it is important to understand what will be disclosed during the clinical development process and when that disclosure will occur.